CELLTECH THERAPEUTICS LTD has a total of 463 patent applications. Its first patent ever was published in 1984. It filed its patents most often in United Kingdom, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BIOGEN, ONKURE INC and FERRING RES LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 118 | |
#2 | United States | 84 | |
#3 | EPO (European Patent Office) | 81 | |
#4 | Australia | 59 | |
#5 | WIPO (World Intellectual Property Organization) | 56 | |
#6 | Canada | 29 | |
#7 | New Zealand | 7 | |
#8 | Hungary | 5 | |
#9 | Ireland | 5 | |
#10 | Norway | 5 | |
#11 | Czechia | 3 | |
#12 | Finland | 3 | |
#13 | Israel | 2 | |
#14 | Slovakia | 2 | |
#15 | South Africa | 2 | |
#16 | China | 1 | |
#17 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Measurement | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Peptides | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Microorganisms | |
#7 | Unspecified technologies | |
#8 | Special acyclic compounds | |
#9 | Analysing materials | |
#10 | Enzymes |
# | Name | Total Patents |
---|---|---|
#1 | Warrellow Graham John | 126 |
#2 | Head John Clifford | 78 |
#3 | Alexander Rikki Peter | 62 |
#4 | Porter John Robert | 61 |
#5 | Archibald Sarah Catherine | 55 |
#6 | Emtage John Spencer | 34 |
#7 | Bodmer Mark William | 33 |
#8 | Athwal Diljeet Singh | 32 |
#9 | Moffat David Festus Charles | 31 |
#10 | Davis Peter David | 31 |
Publication | Filing date | Title |
---|---|---|
US2003060444A1 | Cell activation process and reagents therefor | |
GB0011193D0 | Biological products | |
AU4421200A | Bipolar lipids and their use for the delivery of bioactive substances | |
GB0009712D0 | Chemical compounds | |
GB0009714D0 | Chemical compounds | |
GB0009615D0 | Chemical compounds | |
WO0063374A1 | Synthetic transmembrane components | |
GB0009493D0 | Chemical compounds | |
GB0007657D0 | Chemical compounds | |
GB0007507D0 | Chemical compounds | |
GB0007523D0 | Chemical compound | |
GB0002858D0 | Chemical compounds | |
GB0002872D0 | Chemical compounds | |
GB9930558D0 | Chemical compounds | |
GB9929988D0 | Chemical compounds | |
GB9925853D0 | Biological products | |
GB9925848D0 | Biological products | |
GB9925854D0 | Biological products | |
GB9924862D0 | Chemical compounds | |
GB9924859D0 | Chemical compounds |